Subtopic Deep Dive
Platelet Role in Cancer Metastasis and Thrombosis
Research Guide
What is Platelet Role in Cancer Metastasis and Thrombosis?
Platelets promote cancer metastasis by forming tumor-platelet aggregates that shield circulating tumor cells from immune detection and shear stress while also driving thrombosis through inflammatory signaling.
Platelets interact with tumor cells to facilitate immune evasion, endothelial adhesion, and metastatic seeding in distant organs (Schlesinger, 2018; 646 citations). Elevated platelet-to-lymphocyte ratio (PLR) serves as an inflammatory biomarker predicting poor prognosis across solid tumors (Templeton et al., 2014; 691 citations). Over 10 meta-analyses and reviews since 2014 quantify platelet roles in thrombo-inflammation during cancer progression.
Why It Matters
High PLR correlates with reduced survival in solid tumors, enabling risk stratification for therapies targeting platelet-tumor interactions (Templeton et al., 2014). Platelets drive metastasis by releasing granules that support tumor cell extravasation and angiogenesis, as shown in mouse models (Schlesinger, 2018). Inhibiting platelet activation reduces thrombotic events in cancer patients, improving outcomes in thrombo-inflammatory states (Palacios-Acedo et al., 2019). These mechanisms link systemic inflammation to metastasis, informing antithrombotic strategies.
Key Research Challenges
Heterogeneity in Platelet Biomarkers
PLR and systemic immune-inflammation index (SII) vary across cancer types, complicating prognostic models (Templeton et al., 2014; Yang et al., 2018). Meta-analyses reveal inconsistent cutoffs due to patient comorbidities (Templeton et al., 2014). Standardization requires multi-cohort validation.
Mechanisms of Thrombo-Inflammation
Platelets form aggregates with tumor cells to evade immunity, but pathways linking inflammation to thrombosis remain unclear (Palacios-Acedo et al., 2019; Schlesinger, 2018). Neutrophil-platelet interactions amplify this in tumor microenvironments (Kim and Bae, 2016). In vivo imaging is needed for causal links.
Therapeutic Targeting Risks
Antiplatelet drugs reduce metastasis in preclinical models but increase bleeding risks (Sharma et al., 2013). Balancing antithrombotic benefits against hemorrhage in cancer patients lacks clinical trials (Ho-Tin-Noé et al., 2008). Platelet granule secretion prevents intratumor bleeding, complicating inhibition.
Essential Papers
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Jaehong Kim, Jong‐Sup Bae · 2016 · Mediators of Inflammation · 828 citations
Distinct tumor microenvironment forms in each progression step of cancer and has diverse capacities to induce both adverse and beneficial consequences for tumorigenesis. It is now known that immune...
Neutrophil-to-lymphocyte ratio, past, present and future perspectives
Roman Záhorec · 2021 · Bratislavské lekárske listy/Bratislava medical journal · 801 citations
In the review we analyzed short history of the establishment of a novel hematological parameter for systemic inflammation and stress coined as a neutrophil to lymphocyte ratio (NLR). Today NLR is w...
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton, Olga Ace, Mairéad G. McNamara et al. · 2014 · Cancer Epidemiology Biomarkers & Prevention · 691 citations
Abstract Background: Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor prognosis in sever...
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
Si Zhang, Yangyang Liu, Xiaofang Wang et al. · 2020 · Journal of Hematology & Oncology · 672 citations
Abstract Background Critically ill patients diagnosed with COVID-19 may develop a pro-thrombotic state that places them at a dramatically increased lethal risk. Although platelet activation is crit...
Role of platelets and platelet receptors in cancer metastasis
Martin Schlesinger · 2018 · Journal of Hematology & Oncology · 646 citations
Neutrophils in Cancer: Two Sides of the Same Coin
Eileen Uribe‐Querol, Carlos Rosales · 2015 · Journal of Immunology Research · 418 citations
Neutrophils are the most abundant leukocytes in blood and are considered to be the first line of defense during inflammation and infections. In addition, neutrophils are also found infiltrating man...
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Ruonan Yang, Qian Chang, Xianchun Meng et al. · 2018 · Journal of Cancer · 394 citations
Systemic immune-inflammation index (SII), on the basis of lymphocyte, neutrophil and platelet counts had been published to be a good prognostic factor in multiple cancers. Nevertheless, the prognos...
Reading Guide
Foundational Papers
Start with Templeton et al. (2014; 691 citations) for PLR meta-analysis establishing prognostic value; Sharma et al. (2013) for platelet roles in tumor progression and therapeutic targets.
Recent Advances
Schlesinger (2018; 646 citations) on platelet receptors in metastasis; Palacios-Acedo et al. (2019) on platelets in thrombo-inflammation and cancer.
Core Methods
Blood count-derived ratios (PLR, SII); mouse models of tumor-platelet aggregates; meta-regression of hazard ratios; granule secretion assays.
How PapersFlow Helps You Research Platelet Role in Cancer Metastasis and Thrombosis
Discover & Search
Research Agent uses searchPapers and citationGraph on 'platelet cancer metastasis' to map 691-cited Templeton et al. (2014) as a hub connecting PLR meta-analyses to Schlesinger (2018) on mechanisms. exaSearch uncovers hidden reviews like Palacios-Acedo et al. (2019) on thrombo-inflammation. findSimilarPapers expands to 50+ related works on PLR/SII biomarkers.
Analyze & Verify
Analysis Agent applies readPaperContent to extract PLR hazard ratios from Templeton et al. (2014), then runPythonAnalysis with pandas to meta-analyze survival data across 10 papers, verifying with GRADE scoring for evidence strength. verifyResponse (CoVe) cross-checks claims like platelet shielding against immune cells using Schlesinger (2018) abstracts, flagging contradictions in neutrophil roles (Uribe-Querol and Rosales, 2015).
Synthesize & Write
Synthesis Agent detects gaps in PLR validation for thrombosis via contradiction flagging between Templeton et al. (2014) and Yang et al. (2018). Writing Agent uses latexEditText to draft sections on mechanisms, latexSyncCitations to integrate 20 references, and latexCompile for a review manuscript. exportMermaid generates flowcharts of platelet-tumor aggregate formation from Palacios-Acedo et al. (2019).
Use Cases
"Compute meta-analysis of PLR hazard ratios in solid tumors from recent papers"
Research Agent → searchPapers('PLR cancer prognosis') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on Templeton 2014 + Yang 2018 data) → forest plot CSV with statistical p-values.
"Draft LaTeX review on platelet mechanisms in metastasis"
Synthesis Agent → gap detection (Schlesinger 2018 + Palacios-Acedo 2019) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(15 papers) → latexCompile(PDF) with integrated figures.
"Find code for simulating platelet-tumor aggregation models"
Research Agent → paperExtractUrls(Schlesinger 2018) → Code Discovery → paperFindGithubRepo → githubRepoInspect → validated Python scripts for agent-based metastasis simulation.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(100+ on PLR/thrombosis) → citationGraph → DeepScan(7-step verification with CoVe checkpoints) → structured report on prognostic models. Theorizer generates hypotheses on platelet-neutrophil synergies from Kim and Bae (2016) + Uribe-Querol and Rosales (2015), chaining to runPythonAnalysis for pathway simulations. DeepScan analyzes Templeton et al. (2014) meta-data with GRADE grading and statistical tests.
Frequently Asked Questions
What defines platelet role in cancer metastasis?
Platelets form protective aggregates with tumor cells, promoting survival, immune evasion, and endothelial adhesion for metastatic seeding (Schlesinger, 2018).
What methods quantify platelet inflammation biomarkers?
Platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) from blood counts predict outcomes via meta-analysis of hazard ratios (Templeton et al., 2014; Yang et al., 2018).
What are key papers on this topic?
Templeton et al. (2014; 691 citations) meta-analyzes PLR prognosis; Schlesinger (2018; 646 citations) details platelet receptors in metastasis; Palacios-Acedo et al. (2019) covers thrombo-inflammation.
What open problems exist?
Clinical trials balancing antiplatelet therapy benefits against bleeding risks; standardized PLR cutoffs across cancers; in vivo validation of platelet-tumor signaling pathways.
Research Inflammatory Biomarkers in Disease Prognosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Platelet Role in Cancer Metastasis and Thrombosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers